logoTry Persana

Reshape Biotech - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Reshape Biotech including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Reshape Biotech company logo

Accelerating the pace of R&D.

Reshape Biotech is building the next generation of lab automation robots, focusing on helping biotech companies tackle significant challenges in research through automation and data analysis.

HeadquartersCopenhagen, Denmark
Team size51-100
Founded2018

What is Reshape Biotech? - Company Overview & Details

Reshape Biotech is Reshape Biotech is building the next generation of lab automation robots, focusing on helping biotech companies tackle significant challenges in research through automation and data analysis. Founded in 2018, the company is headquartered in Copenhagen, Denmark.

Who Founded Reshape Biotech?

Reshape Biotech was founded by Carl-Emil Grøn, Magnus Madsen, Daniel Storgaard.

Who are the Key Executives at Reshape Biotech? - Leadership Team

Reshape Biotech is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Reshape Biotech

Carl-Emil GrønCEO

About Carl-Emil Grøn - CEO of Reshape Biotech

Carl-Emil Grøn serves as the Chief Executive Officer of Reshape Biotech, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Reshape Biotech Company Details & Key Information

Where is Reshape Biotech located?

Reshape Biotech is headquartered in Copenhagen, Denmark.

How many employees does Reshape Biotech have?

Reshape Biotech has 51-100 employees.

When was Reshape Biotech founded?

Reshape Biotech was founded in 2018.

Reshape Biotech Official Website

How much funding has Reshape Biotech raised?

Reshape Biotech has raised $27.2 Million across 2 funding rounds. The most recent funding was completed on 2024-05-09.

Funding Overview

Reshape Biotech has raised a total of $27.2 million through a seed round and a subsequent Series A round to support its lab automation developments.

$27.2 Million
Total Funding Raised
2
Funding Rounds
2024-05-09
Latest Round

Reshape Biotech Funding History

Seed
2023-02-09
$8.1 Million
Series A
2024-05-09
$20 Million

Who are the key investors in Reshape Biotech?

Reshape Biotech is backed by 3 key investors including Astanor Ventures, ACME Capital, Y Combinator. These investors focus on Biotechnology, Sustainable Agriculture, Various sectors.

Reshape Biotech Investor Overview

3
Key Investors
4
Focus Areas
0
Notable Investments

Complete List of Reshape Biotech Investors

Astanor Ventures

A VC firm focused on investments in sustainable food and agriculture.

Investment Focus
Biotechnology
Sustainable Agriculture

ACME Capital

Investment Focus
Various

Y Combinator

A startup accelerator known for funding early-stage startups.

Investment Focus
Startup Development

What sectors do Reshape Biotech investors focus on?

The investors backing Reshape Biotech primarily focus on Biotechnology, Sustainable Agriculture, Various, Startup Development sectors.

Biotechnology
Sustainable Agriculture
Various
Startup Development

Featured Investor: Astanor Ventures

Astanor Ventures

A VC firm focused on investments in sustainable food and agriculture.

Notable Investments:

What are Reshape Biotech's future plans?

Reshape Biotech Reshape plans to expand its presence in the U.S. market and develop new features for its automation technologies.

Reshape Biotech Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Reshape Biotech face?

Reshape Biotech has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Reshape Biotech

1

Scaling operations internationally

2

Competition in the lab automation market

What opportunities does Reshape Biotech have?

Reshape Biotech has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Reshape Biotech

1

Expanding product offerings

2

Attracting more customers in North America

Reshape Biotech Strategic Position Summary

Key Focus Areas

Reshape Biotech is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Reshape Biotech?

Reshape Biotech has 2 recent news updates covering key business developments and market activities.

Reshape Biotech News Overview

2
Recent Articles
Active
Media Coverage
2024-04-15
Latest Update

What is Reshape Biotech in the news for?

Reshape Biotech is currently featured in news for Reshape Biotech launched revamped imaging system on Apr 15th '23. and other significant business developments.

Recent News Articles About Reshape Biotech

Article 1
2024-04-15

Reshape Biotech launched revamped imaging system on Apr 15th '23.

Reshape Biotech has raised $20 million in Series A funding for advanced biological research automation.

arcticstartup.com
Read News
Article 2
2024-04-09

Reshape Biotech receives financing of $20M in Series A.

Reshape is building the next generation of lab automation robots and has raised $20 million in a Series A funding round.

tech.eu
Read News

Reshape Biotech FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Reshape Biotech including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Reshape Biotech Questions & Answers - Company Information

Q1

What is Reshape Biotech?

Reshape Biotech is building the next generation of lab automation robots, focusing on helping biotech companies tackle significant challenges in research through automation and data analysis.

Q2

Who founded Reshape Biotech?

Reshape Biotech was founded by Carl-Emil Grøn, Magnus Madsen, Daniel Storgaard.

Q3

Who is the CEO of Reshape Biotech?

The CEO of Reshape Biotech is Carl-Emil Grøn. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Reshape Biotech raised?

Reshape Biotech has raised a total of $$27.2 Million across 2 funding rounds. The most recent funding was completed on 2024-05-09.

Q5

Who are the investors in Reshape Biotech?

Reshape Biotech's key investors include Astanor Ventures, ACME Capital, Y Combinator.

Q6

Where is Reshape Biotech headquartered?

Reshape Biotech is headquartered in Copenhagen, Denmark.

Q7

When was Reshape Biotech founded?

Reshape Biotech was founded in 2018.

Q8

How many employees does Reshape Biotech have?

Reshape Biotech has 51-100 employees.

Q9

What is Reshape Biotech's official website?

You can visit Reshape Biotech's official website at http://reshapebiotech.com.

Q10

What was Reshape Biotech's latest funding round?

Reshape Biotech's latest funding round was a Seed round of $$8.1 Million completed on 2023-02-09.

Q11

Who is founder?

Carl-Emil Grøn

Q12

What does the company do?

Reshape Biotech is developing lab automation robots for biotechnology which aim to enhance the research process.

Q13

How much funding?

$27.2 Million

Q14

Latest funding date?

2024-05-09

Q15

Who are the investors?

Astanor Ventures ACME Capital Y Combinator

Q16

What are the challenges?

Scaling operations internationally Competition in the lab automation market

Q17

What are the opportunities?

Expanding product offerings Attracting more customers in North America

Q18

Latest news?

Reshape Biotech has raised $20 million in Series A funding for advanced biological research automation. Reshape is building the next generation of lab automation robots and has raised $20 million in a Series A funding round.

More Information About Reshape Biotech

For additional details about Reshape Biotech, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.